Author

M. J. Yaeger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Assay:flow cytometry· 1 Organism:human· 1

Frequent Co-Authors

K. M. Gowdy· 2 shared A. Birukova· 1 shared A. T. Vose· 1 shared A. V. Misharin· 1 shared B. K. Sreekumar· 1 shared C. J. Salazar· 1 shared D. M. Jones· 1 shared E. Bunyan· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

K. M. Gowdy

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tissue-resident alveolar macrophages reduce O3-induced inflammation via MerTK mediated efferocytosis

M. A. Guttenberg, A. T. Vose, A. Birukova, K. Lewars, R. I. Cumming, M. C. Albright, J. I. Mark, C. J. Salazar, S. Swaminathan, Z. Yu, Y. V. Sokolenko, E. Bunyan, M. J. Yaeger, M. B. Fessler, L. G. Que, , R. M. Tighe

This study shows tissue-resident alveolar macrophages reduce O3-induced inflammation by clearing apoptotic cells via MerTK-mediated efferocytosis in mice and humans.

bioRxiv · Nov 6, 2023 · PreprintImmunology

Eos promotes TH2 differentiation by propagating the IL-2/STAT5 signaling pathway.

J. A. Tuazon, K. A. Read, B. K. Sreekumar, M. J. Yaeger, S. Varikuti, D. M. Jones, R. T. Warren, M. D. Powell, M. N. Rasheed, E. G. Duncan, L. M. Childs, K. M. Gowdy, K. J. Oestreich

This study identifies Eos as a positive regulator of TH2 cell differentiation by enhancing IL-2/STAT5 signaling in CD4+ T cells.

bioRxiv · Nov 2, 2022 · PreprintImmunology